Stockreport

CytoDyn reports leronlimab data in NASH trial for first 15 patients [Seeking Alpha]

CYTODYN INC  (CYDY) 
NASDAQ:AMEX Investor Relations: ir.cytodyn.com
PDF CytoDyn reports leronlimab data in NASH trial for first 15 patients [Read more]